Menu
Recruiting NCT07306338

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

— Observational Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Non-Interventional Study.
Who it may be relevant to
Registry conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study assesses patient perspectives on the interest in, feasibility, and acceptability of an Integrative Oncology Program for patients at USC NCCC and HC3 Women's Clinic.

Detailed description

PRIMARY OBJECTIVE:

I. To measure patient knowledge, attitudes, and interest in IO program services, identify predictors of willingness to participate or refer, and potential barriers to implementation into existing clinical care workflows.

OUTLINE: This is an observational study.

Patients complete a survey and may participate in a focus group on study.

Interventions

  • Other Non-Interventional Study
    Non-interventional study

Primary outcome measures

  • Patient knowledge about Integrative Oncology (IO) program services [Time frame: Through study completion, up to 1 year]
  • Patient attitudes about IO program services [Time frame: Through study completion, up to 1 year]
  • Patient interest in IO program services [Time frame: Through study completion, up to 1 year]
  • Predictors of willingness to participate or refer [Time frame: Through study completion, up to 1 year]
  • Potential barriers to implementation [Time frame: Through study completion, up to 1 year]

Eligibility criteria

Inclusion criteria

  • Age ≥ 18 years
  • Ability to understand and the willingness to participate in the study.
  • English, Spanish, or Chinese speaking
  • Patient of USC NCCC Outpatient Clinics or Keck HC3 Women's Health outpatient clinic.
  • Diagnosed solid or hematologic Malignancy

Exclusion criteria

  • Unable to provide informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

United States · 1 center
  • USC / Norris Comprehensive Cancer Center — Los Angeles

Identifiers

NCT: NCT07306338 · 0S-25-3 · NCI-2025-09248 · UP-25-00895 · 0S-25-3 · P30CA014089

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗